GAFFX
Price
$85.14
Change
+$0.99 (+1.18%)
Updated
Jul 31 closing price
Net Assets
356.86B
SGNFX
Price
$53.81
Change
+$0.61 (+1.15%)
Updated
Jul 31 closing price
Net Assets
72.96M
Interact to see
Advertisement

GAFFX vs SGNFX

GAFFX vs SGNFX Comparison Chart in %
View a ticker or compare two or three
VS
GAFFX vs. SGNFX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and SGNFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 357B vs. SGNFX (73M). GAFFX pays higher dividends than SGNFX: GAFFX (0.53) vs SGNFX (0.00). GAFFX was incepted earlier than SGNFX: GAFFX (10 years) vs SGNFX (26 years). SGNFX (1.28) is less costly to investors than GAFFX (0.29). GAFFX is a more actively managed with annual turnover of: 32.00 vs. SGNFX (2.25). SGNFX has a lower initial minimum investment than GAFFX: SGNFX (2500) vs GAFFX (1000000). SGNFX annual gain was more profitable for investors over the last year : 5.74 vs. GAFFX (1.95). GAFFX return over 5 years is better than : 15.04 vs. SGNFX (10.42).
GAFFXSGNFXGAFFX / SGNFX
Total Expense Ratio0.291.2823%
Annual Report Gross Expense Ratio0.291.2823%
Fund Existence10 years26 years-
Gain YTD5.7900.900643%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets357B73M489,041%
Annual Yield % from dividends0.530.00-
Returns for 1 year1.955.7434%
Returns for 3 years37.3763.4659%
Returns for 5 years15.0410.42144%
Returns for 10 yearsN/A218.40-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ISBAX16.770.16
+0.96%
VY® Columbia Contrarian Core A
FIKYX14.840.02
+0.13%
Fidelity Advisor Asset Manager 40% Z
EPSRX29.06-0.05
-0.17%
NYLI Epoch Global Equity Yield Class R6
MVCAX34.49-0.11
-0.32%
MFS Mid Cap Value A
DRLAX9.94-0.08
-0.80%
BNY Mellon Developed Markets RE Scs - A